226
|
Petrylak D, Smith D, Appleman L, Fleming M, Hussain A, Dreicer R, Sartor O, Shore N, Vogelzang N, Youssoufian H, Stambler N, Huang K, Israel R. 870 A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC). ACTA ACUST UNITED AC 2014. [DOI: 10.1016/s1569-9056(14)60857-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
227
|
Liu J, Ye G, Zhou Y, Liu Y, Zhao L, Liu Y, Chen X, Huang D, Liao SF, Huang K. Feeding glycerol-enriched yeast culture improves performance, energy status, and heat shock protein gene expression of lactating Holstein cows under heat stress. J Anim Sci 2014; 92:2494-502. [PMID: 24668959 DOI: 10.2527/jas.2013-7152] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
This study was conducted to evaluate the effects of supplemental common yeast culture (CY) and glycerol-enriched yeast culture (GY) on performance, plasma metabolites, antioxidant status, and heat shock protein 70 (HSP70) mRNA expression in lactating Holstein cows under heat stress. During summer months, 30 healthy multiparous lactating cows (parity 3.25 ± 0.48; 60 ± 13 d in milk [DIM]; 648 ± 57 kg BW; an average milk yield of 33.8 ± 1.6 kg/d) were blocked by parity, previous milk yield, and DIM and randomly allocated to 3 dietary treatments: no supplemental yeast culture (Control), 1 L/d of CY (33.1 g yeast) per cow, and 2 L/d of GY (153.2 g glycerol and 31.6 g yeast) per cow. During the 60-d experiment, values of air temperature and relative humidity inside the barn were recorded hourly every 3 d to calculate temperature-humidity index (THI). Weekly rectal temperatures (RT) and respiration rates and daily DMI and milk yield were recorded for all cows. Milk and blood samples were taken twice monthly, and BW and BCS were obtained on d 0 and 60. In this experiment, THI values indicated cows experienced a moderate heat stress. Cows supplemented with CY and GY had greater yields of milk, energy-corrected milk and milk fat, and milk fat percent but lower HSP70 mRNA expression in peripheral blood lymphocytes than Control cows (P < 0.05). Supplementing CY and GY tended (P < 0.15) to decrease RT at 1400 h, increase milk protein yield and erythrocyte glutathione, and reduce plasma urea nitrogen compared with Control. Lower plasma NEFA concentration and HSP70 mRNA expression in peripheral blood lymphocytes (P < 0.05) and tendencies towards greater plasma glucose concentration (P = 0.11) but less BW loss (P = 0.14) were observed in GY relative to CY cows. In conclusion, either CY or GY supplementation partially mitigated the negative effects of heat stress on performance and HSP70 mRNA expression of lactating cows, and GY supplementation provided additional improvements in energy status and HSP70 gene expression of lactating cows.
Collapse
|
228
|
Renshaw A, Abe K, Hayato Y, Iyogi K, Kameda J, Kishimoto Y, Miura M, Moriyama S, Nakahata M, Nakano Y, Nakayama S, Sekiya H, Shiozawa M, Suzuki Y, Takeda A, Takenaga Y, Tomura T, Ueno K, Yokozawa T, Wendell RA, Irvine T, Kajita T, Kaneyuki K, Lee KP, Nishimura Y, Okumura K, McLachlan T, Labarga L, Berkman S, Tanaka HA, Tobayama S, Kearns E, Raaf JL, Stone JL, Sulak LR, Goldhabar M, Bays K, Carminati G, Kropp WR, Mine S, Smy MB, Sobel HW, Ganezer KS, Hill J, Keig WE, Hong N, Kim JY, Lim IT, Akiri T, Himmel A, Scholberg K, Walter CW, Wongjirad T, Ishizuka T, Tasaka S, Jang JS, Learned JG, Matsuno S, Smith SN, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Suzuki AT, Takeuchi Y, Bronner C, Hirota S, Huang K, Ieki K, Ikeda M, Kikawa T, Minamino A, Nakaya T, Suzuki K, Takahashi S, Fukuda Y, Choi K, Itow Y, Mitsuka G, Mijakowski P, Hignight J, Imber J, Jung CK, Yanagisawa C, Ishino H, Kibayashi A, Koshio Y, Mori T, Sakuda M, Yano T, Kuno Y, Tacik R, Kim SB, Okazawa H, Choi Y, Nishijima K, Koshiba M, Totsuka Y, Yokoyama M, Martens K, Marti L, Vagins MR, Martin JF, de Perio P, Konaka A, Wilking MJ, Chen S, Zhang Y, Wilkes RJ. First indication of terrestrial matter effects on solar neutrino oscillation. PHYSICAL REVIEW LETTERS 2014; 112:091805. [PMID: 24655245 DOI: 10.1103/physrevlett.112.091805] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2013] [Indexed: 06/03/2023]
Abstract
We report an indication that the elastic scattering rate of solar B8 neutrinos with electrons in the Super-Kamiokande detector is larger when the neutrinos pass through Earth during nighttime. We determine the day-night asymmetry, defined as the difference of the average day rate and average night rate divided by the average of those two rates, to be [-3.2 ± 1.1(stat) ± 0.5(syst)]%, which deviates from zero by 2.7 σ. Since the elastic scattering process is mostly sensitive to electron-flavored solar neutrinos, a nonzero day-night asymmetry implies that the flavor oscillations of solar neutrinos are affected by the presence of matter within the neutrinos' flight path. Super-Kamiokande's day-night asymmetry is consistent with neutrino oscillations for 4 × 10(-5) eV(2) ≤ Δm 2(21) ≤ 7 × 10(-5) eV(2) and large mixing values of θ12, at the 68% C.L.
Collapse
|
229
|
Tablin F, Schumacher T, Pombo M, Marion CT, Huang K, Norris JW, Jandrey KE, Kittleson MD. Platelet activation in cats with hypertrophic cardiomyopathy. J Vet Intern Med 2014; 28:411-8. [PMID: 24612013 PMCID: PMC4857988 DOI: 10.1111/jvim.12325] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2013] [Revised: 11/21/2013] [Accepted: 01/09/2014] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described. OBJECTIVES To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1). ANIMALS Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied. METHODS Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed. RESULTS Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats. CONCLUSIONS AND CLINICAL IMPORTANCE P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.
Collapse
|
230
|
Abe K, Adam J, Aihara H, Akiri T, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Cremonesi L, Dabrowska A, Danko I, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis SR, Densham C, Di Lodovico F, Di Luise S, Drapier O, Duboyski T, Duffy K, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Emery S, Ereditato A, Escudero L, Finch AJ, Floetotto L, Friend M, Fujii Y, Fukuda Y, Furmanski AP, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Goeldi D, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Hadley DR, Haesler A, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Huang K, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine TJ, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Jung CK, Kaboth AC, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, Kisiel J, Kitching P, Kobayashi T, Koch L, Kolaceke A, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Lamont I, Laveder M, Lawe M, Lazos M, Lee KP, Licciardi C, Lindner T, Lister C, Litchfield RP, Longhin A, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Mathie EL, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Owen RA, Oyama Y, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Petrov Y, Pickard LJ, Pinzon Guerra ES, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reeves M, Reinherz-Aronis E, Retiere F, Robert A, Rodrigues PA, Rojas P, Rondio E, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Tanaka MM, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Zmuda J. Observation of electron neutrino appearance in a muon neutrino beam. PHYSICAL REVIEW LETTERS 2014; 112:061802. [PMID: 24580687 DOI: 10.1103/physrevlett.112.061802] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2013] [Indexed: 06/03/2023]
Abstract
The T2K experiment has observed electron neutrino appearance in a muon neutrino beam produced 295 km from the Super-Kamiokande detector with a peak energy of 0.6 GeV. A total of 28 electron neutrino events were detected with an energy distribution consistent with an appearance signal, corresponding to a significance of 7.3σ when compared to 4.92±0.55 expected background events. In the Pontecorvo-Maki-Nakagawa-Sakata mixing model, the electron neutrino appearance signal depends on several parameters including three mixing angles θ12, θ23, θ13, a mass difference Δm(32)(2) and a CP violating phase δ(CP). In this neutrino oscillation scenario, assuming |Δm(32)(2)|=2.4×10(-3) eV(2), sin(2)θ(23)=0.5, and Δm322>0 (Δm(32)(2)<0), a best-fit value of sin(2)2θ(13)=0.140(-0.032)(+0.038) (0.170(-0.037)(+0.045)) is obtained at δ(CP)=0. When combining the result with the current best knowledge of oscillation parameters including the world average value of θ(13) from reactor experiments, some values of δ(CP) are disfavored at the 90% C.L.
Collapse
|
231
|
Hu M, Hyun J, Wu J, Li S, Lo D, Chung M, Huang K, Hu M, McArdle A, Longaker M, Lorenz H. Blood-Derived Mesenchymal Stem Cells Heal Calvarial Defects. J Surg Res 2014. [DOI: 10.1016/j.jss.2013.11.970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
232
|
Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K, Feng S, Bao X, Huang K, He X, Liang P, Wang Z, Tang H, He J, Zhang B. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene 2014; 34:691-703. [PMID: 24469051 DOI: 10.1038/onc.2013.597] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2013] [Revised: 11/10/2013] [Accepted: 12/16/2013] [Indexed: 12/26/2022]
Abstract
The tumor suppressor p53, nuclear factor-κB (NF-κB) and reactive oxygen species (ROS) have crucial roles in tumorigenesis, although the mechanisms of cross talk between these factors remain largely unknown. Here we report that miR-506 upregulation occurs in 83% of lung cancer patients (156 cases), and its expression highly correlates with ROS. Ectopic expression of miR-506 inhibits NF-κB p65 expression, induces ROS accumulation and then activates p53 to suppress lung cancer cell viability, but not in normal cells. Interestingly, p53 promotes miR-506 expression level, indicating that miR-506 mediates cross talk between p53, NF-κB p65 and ROS. Furthermore, we demonstrated that miR-506 mimics inhibited tumorigenesis in vivo, implicating that miR-506 might be a potential therapeutic molecule for selective killing of lung cancer cells.
Collapse
|
233
|
Liu BL, Wang JB, Zhong XL, Huang K, Li B, Wang F, Xie J, Zhou YC. Enhanced electrocaloric effect in a Ba(1−x)SrxTiO3 compositionally graded film. RSC Adv 2014. [DOI: 10.1039/c4ra01875c] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
234
|
Huang K, Toride N, Van Genuchten MT. Experimental investigation of solute transport in large, homogeneous and heterogeneous, saturated soil columns. Transp Porous Media 2013. [DOI: 10.1007/bf00616936] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
235
|
Abe K, Adam J, Aihara H, Akiri T, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Cremonesi L, Curioni A, Dabrowska A, Danko I, Das R, Davis S, de Perio P, De Rosa G, Dealtry T, Dennis SR, Densham C, Di Lodovico F, Di Luise S, Drapier O, Duboyski T, Duffy K, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Emery S, Ereditato A, Escudero L, Finch AJ, Frank E, Friend M, Fujii Y, Fukuda Y, Furmanski AP, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Hadley DR, Haesler A, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Hirota S, Holeczek J, Horikawa S, Huang K, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine TJ, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Joo KK, Jung CK, Kaboth AC, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim J, Kim SB, Kisiel J, Kitching P, Kobayashi T, Kogan G, Kolaceke A, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Laveder M, Lawe M, Lazos M, Lee KP, Licciardi C, Lim IT, Lindner T, Lister C, Litchfield RP, Longhin A, Lopez GD, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Masliah P, Mathie EL, Matveev V, Mavrokoridis K, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Metelko C, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, O'Keeffe HM, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Otani M, Owen RA, Oyama Y, Pac MY, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Petrov Y, Pinzon Guerra ES, Pistillo C, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Redij A, Reeves M, Reinherz-Aronis E, Retiere F, Robert A, Rodrigues PA, Rondio E, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Sato F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suda Y, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Tanaka MM, Taylor IJ, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Zmuda J. Measurement of neutrino oscillation parameters from muon neutrino disappearance with an off-axis beam. PHYSICAL REVIEW LETTERS 2013; 111:211803. [PMID: 24313479 DOI: 10.1103/physrevlett.111.211803] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2013] [Revised: 10/09/2013] [Indexed: 06/02/2023]
Abstract
The T2K Collaboration reports a precision measurement of muon neutrino disappearance with an off-axis neutrino beam with a peak energy of 0.6 GeV. Near detector measurements are used to constrain the neutrino flux and cross section parameters. The Super-Kamiokande far detector, which is 295 km downstream of the neutrino production target, collected data corresponding to 3.01×10(20) protons on target. In the absence of neutrino oscillations, 205±17 (syst) events are expected to be detected while only 58 muon neutrino event candidates are observed. A fit to the neutrino rate and energy spectrum, assuming three neutrino flavors and normal mass hierarchy yields a best-fit mixing angle sin2(θ23)=0.514±0.082 and mass splitting |Δm(32)(2)|=2.44(-0.15)(+0.17)×10(-3) eV2/c4. Our result corresponds to the maximal oscillation disappearance probability.
Collapse
|
236
|
Zhang Y, Tang YJ, Li ZH, Pan F, Huang K, Xu GH. KiSS1 inhibits growth and invasion of osteosarcoma cells through inhibition of the MAPK pathway. Eur J Histochem 2013; 57:e30. [PMID: 24441183 PMCID: PMC3896032 DOI: 10.4081/ejh.2013.e30] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2013] [Revised: 09/16/2013] [Accepted: 09/17/2013] [Indexed: 01/05/2023] Open
Abstract
As a metastasis suppressor, KiSS1 has been implicated in numerous human cancers. However, recent studies have demonstrated that KiSS1 promotes tumor growth and metastasis in breast cancer, and it is unclear about the expression and function of KiSS1 in human osteosarcoma (OS). The aim of the present study was to investigate the role and molecular mechanisms of KiSS1 in human OS. The expression of KiSS1 was assessed by immunohistochemical assay using a tissue microarray procedure in forty cases of OS tissues. A gain-of-function approach was used to observe the effects of lentiviral vector-mediated overexpression of KiSS1 (Lv-KiSS1) on the biological behaviors including proliferative activities and invasive potential of OS MG-63 cells, indicated by MTT and Transwell assays, respectively. The results showed that the expression of KiSS1 protein in OS tissues was significantly lowered compared to that in adjacent non-cancerous tissues (ANCT) (42.5% vs 70.0%, P=0.023), and had negative correlation with distant metastases of the tumor (P=0.019). Overexpression of KiSS1 inhibited proliferation and invasion of OS cells with the decreased expression of p38 MAPK and matrix metalloproteinase-9 (MMP-9). Taken together, our findings indicate that the decreased expression of KiSS1 is correlated with distant metastasis of OS, and KiSS1 may function as a tumor suppressor in OS cells through inhibition of the MAPK pathway, suggesting that KiSS1 may serve as a potential therapeutic target for the treatment of cancer.
Collapse
|
237
|
Wolowiec CT, White BD, Jeon I, Yazici D, Huang K, Maple MB. Enhancement of superconductivity near the pressure-induced semiconductor-metal transition in the BiS₂-based superconductors LnO₀.₅F₀.₅BiS₂ (Ln = La, Ce, Pr, Nd). JOURNAL OF PHYSICS. CONDENSED MATTER : AN INSTITUTE OF PHYSICS JOURNAL 2013; 25:422201. [PMID: 24067344 DOI: 10.1088/0953-8984/25/42/422201] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Measurements of electrical resistivity were performed between 3 and 300 K at various pressures up to 2.8 GPa on the BiS2-based superconductors LnO0.5F0.5BiS2 (Ln=Pr, Nd). At lower pressures, PrO0.5F0.5BiS2 and NdO0.5F0.5BiS2 exhibit superconductivity with critical temperatures Tc of 3.5 and 3.9 K, respectively. As pressure is increased, both compounds undergo a transition at a pressure Pt from a low Tc superconducting phase to a high Tc superconducting phase in which Tc reaches maximum values of 7.6 and 6.4 K for PrO0.5F0.5BiS2 and NdO0.5F0.5BiS2, respectively. The pressure-induced transition is characterized by a rapid increase in Tc within a small range in pressure of ∼0.3 GPa for both compounds. In the normal state of PrO0.5F0.5BiS2, the transition pressure Pt correlates with the pressure where the suppression of semiconducting behaviour saturates. In the normal state of NdO0.5F0.5BiS2, Pt is coincident with a semiconductor-metal transition. This behaviour is similar to the results recently reported for the LnO0.5F0.5BiS2 (Ln=La, Ce) compounds. We observe that Pt and the size of the jump in Tc between the two superconducting phases both scale with the lanthanide element in LnO0.5F0.5BiS2 (Ln=La, Ce, Pr, Nd).
Collapse
|
238
|
Stoyanova R, Parra A, Huang K, Panoff J, Ishkanian F, Lally B, Gupta R, Roy B, Maudsley A, Markoe A. 3D Spectroscopy Evaluation of GBM Treatment Volumes. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
239
|
Huang K, Wu B, Ding X, Xu Z, Tang H. 304 * RETROSTERNAL ROUTE GASTROSTOMY FEEDING FOR PATIENTS UNDERGOING OESOPHAGECTOMY AND RECEIVING RETROSTERNAL GASTRIC TUBE RECONSTRUCTION: A RETROSPECTIVE PRAGMATIC STUDY. Interact Cardiovasc Thorac Surg 2013. [DOI: 10.1093/icvts/ivt372.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
240
|
Chen W, Di X, Wang S, Wang B, Bai X, Yang J, Guo B, Huang K. SU-E-T-39: A Study of Dose Response Characteristic for Gafchromic EBT2 Film. Med Phys 2013. [DOI: 10.1118/1.4814474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
241
|
Abe K, Abgrall N, Aihara H, Akiri T, Albert JB, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Beznosko D, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Boyd S, Brailsford D, Bravar A, Bronner C, Brook-Roberge DG, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Cremonesi L, Curioni A, Dabrowska A, Danko I, Das R, Davis S, Day M, de André JPAM, de Perio P, De Rosa G, Dealtry T, Dennis SR, Densham C, Di Lodovico F, Di Luise S, Dobson J, Drapier O, Duboyski T, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Dziomba M, Emery S, Ereditato A, Escudero L, Finch AJ, Frank E, Friend M, Fujii Y, Fukuda Y, Furmanski AP, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Guzowski P, Hadley DR, Haesler A, Haigh MD, Hamilton P, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hierholzer M, Hignight J, Hillairet A, Himmel A, Hiraki T, Holeczek J, Horikawa S, Huang K, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Irvine TJ, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jacob A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Joo KK, Jung CK, Kaboth A, Kaji H, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khanam F, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim JY, Kim J, Kim SB, Kirby B, Kisiel J, Kitching P, Kobayashi T, Kogan G, Kolaceke A, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kowalik K, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Laing A, Laveder M, Lawe M, Lee KP, Licciardi C, Lim IT, Lindner T, Lister C, Litchfield RP, Longhin A, Lopez GD, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marchionni A, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Masliah P, Mathie EL, Matveev V, Mavrokoridis K, Mazzucato E, McCauley N, McFarland KS, McGrew C, McLachlan T, Messina M, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakajima K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nicholls TC, Nielsen C, Nishikawa K, Nishimura Y, O’Keeffe HM, Obayashi Y, Ohta R, Okumura K, Okusawa T, Oryszczak W, Oser SM, Otani M, Owen RA, Oyama Y, Pac MY, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Pinzon Guerra ES, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MAM, Reeves M, Reinherz-Aronis E, Retiere F, Robert A, Rodrigues PA, Rondio E, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Scully DI, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shibata M, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Szeptycka M, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HA, Tanaka MM, Tanaka M, Taylor IJ, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wang J, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Measurement of the inclusiveνμcharged current cross section on carbon in the near detector of the T2K experiment. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.092003] [Citation(s) in RCA: 83] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
242
|
Zhao X, Xu N, Li X, Gong Y, Huang K. Long Term Stability Study of a Solid Oxide Metal-Air Battery. ACTA ACUST UNITED AC 2013. [DOI: 10.1149/04529.0113ecst] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
243
|
Huang K, Dahele M, Senan S, Guckenburger M, Rodrigues G, Ward A, Boldt RG, Palma DA. Radiographic Changes After Lung Stereotactic Ablative Radiotherapy (SABR) -- Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature. Pract Radiat Oncol 2013; 3:S11-2. [PMID: 24674475 DOI: 10.1016/j.prro.2013.01.039] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
244
|
Abe K, Abgrall N, Aihara H, Akiri T, Albert JB, Andreopoulos C, Aoki S, Ariga A, Ariga T, Assylbekov S, Autiero D, Barbi M, Barker GJ, Barr G, Bass M, Batkiewicz M, Bay F, Bentham SW, Berardi V, Berger BE, Berkman S, Bertram I, Beznosko D, Bhadra S, Blaszczyk FDM, Blondel A, Bojechko C, Boyd S, Bravar A, Bronner C, Brook-Roberge DG, Buchanan N, Calland RG, Caravaca Rodríguez J, Cartwright SL, Castillo R, Catanesi MG, Cervera A, Cherdack D, Christodoulou G, Clifton A, Coleman J, Coleman SJ, Collazuol G, Connolly K, Curioni A, Dabrowska A, Danko I, Das R, Davis S, Day M, de André JPAM, de Perio P, De Rosa G, Dealtry T, Densham C, Di Lodovico F, Di Luise S, Dobson J, Duboyski T, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Dziomba M, Emery S, Ereditato A, Escudero L, Esposito LS, Finch AJ, Frank E, Friend M, Fujii Y, Fukuda Y, Galymov V, Gaudin A, Giffin S, Giganti C, Gilje K, Golan T, Gomez-Cadenas JJ, Gonin M, Grant N, Gudin D, Guzowski P, Hadley DR, Haesler A, Haigh MD, Hansen D, Hara T, Hartz M, Hasegawa T, Hastings NC, Hayato Y, Hearty C, Helmer RL, Hignight J, Hillairet A, Himmel A, Hiraki T, Holeczek J, Horikawa S, Huang K, Hyndman A, Ichikawa AK, Ieki K, Ieva M, Ikeda M, Imber J, Insler J, Ishida T, Ishii T, Ives SJ, Iyogi K, Izmaylov A, Jamieson B, Johnson RA, Jo JH, Jonsson P, Joo KK, Jover-Manas GV, Jung CK, Kaji H, Kajita T, Kakuno H, Kameda J, Kanazawa Y, Karlen D, Karpikov I, Kearns E, Khabibullin M, Khanam F, Khotjantsev A, Kielczewska D, Kikawa T, Kilinski A, Kim JY, Kim J, Kim SB, Kirby B, Kisiel J, Kitching P, Kobayashi T, Kogan G, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kowalik K, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kumaratunga S, Kurjata R, Kutter T, Lagoda J, Laihem K, Laing A, Laveder M, Lawe M, Lee KP, Licciardi C, Lim IT, Lindner T, Lister C, Litchfield RP, Longhin A, Lopez GD, Ludovici L, Macaire M, Magaletti L, Mahn K, Malek M, Manly S, Marchionni A, Marino AD, Marteau J, Martin JF, Maruyama T, Marzec J, Masliah P, Mathie EL, Matsumura C, Matsuoka K, Matveev V, Mavrokoridis K, Mazzucato E, McCauley N, McFarland KS, McGrew C, McLachlan T, Messina M, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert A, Miura M, Monfregola L, Moriyama S, Mueller TA, Murakami A, Murdoch M, Murphy S, Myslik J, Nagasaki T, Nakadaira T, Nakahata M, Nakai T, Nakajima K, Nakamura K, Nakayama S, Nakaya T, Nakayoshi K, Naples D, Nicholls TC, Nielsen C, Nishikawa K, Nishimura Y, O’Keeffe HM, Obayashi Y, Ohta R, Okumura K, Oryszczak W, Oser SM, Otani M, Owen RA, Oyama Y, Pac MY, Palladino V, Paolone V, Payne D, Pearce GF, Perevozchikov O, Perkin JD, Pinzon Guerra ES, Plonski P, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radicioni E, Ratoff PN, Ravonel M, Rayner MA, Reeves M, Reinherz-Aronis E, Retiere F, Rodrigues PA, Rondio E, Rossi B, Roth S, Rubbia A, Ruterbories D, Sacco R, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Scully DI, Seiya Y, Sekiguchi T, Sekiya H, Shibata M, Shiozawa M, Short S, Shustrov Y, Sinclair P, Smith B, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Stamoulis P, Steinmann J, Still B, Sulej R, Suzuki A, Suzuki K, Suzuki SY, Suzuki Y, Szeglowski T, Szeptycka M, Tacik R, Tada M, Takahashi S, Takeda A, Takeuchi Y, Tanaka HA, Tanaka M, Tanaka MM, Taylor IJ, Terhorst D, Terri R, Thompson LF, Thorley A, Tobayama S, Toki W, Tomura T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Waldron AV, Walter CW, Wang J, Wark D, Wascko MO, Weber A, Wendell R, Wikström G, Wilkes RJ, Wilking MJ, Wilkinson C, Williamson Z, Wilson JR, Wilson RJ, Wongjirad T, Yamada Y, Yamamoto K, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yuan T, Zalewska A, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. T2K neutrino flux prediction. Int J Clin Exp Med 2013. [DOI: 10.1103/physrevd.87.012001 10.1103/physrevd.87.019902] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
245
|
Fernández-Aparicio M, Huang K, Wafula EK, Honaas LA, Wickett NJ, Timko MP, dePamphilis CW, Yoder JI, Westwood JH. Application of qRT-PCR and RNA-Seq analysis for the identification of housekeeping genes useful for normalization of gene expression values during Striga hermonthica development. Mol Biol Rep 2012; 40:3395-407. [DOI: 10.1007/s11033-012-2417-y] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2012] [Accepted: 12/18/2012] [Indexed: 12/11/2022]
|
246
|
Zhang H, Pu J, Qi T, Qi M, Yang C, Li S, Huang K, Zheng L, Tong Q. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene 2012; 33:387-97. [PMID: 23222716 DOI: 10.1038/onc.2012.574] [Citation(s) in RCA: 117] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2012] [Revised: 10/01/2012] [Accepted: 10/23/2012] [Indexed: 11/10/2022]
Abstract
Recent evidence shows that hypoxia-inducible factor 2 alpha (HIF-2α) may have critical roles in the growth and progression of neuroblastoma (NB) under non-hypoxic conditions. However, the underlying mechanisms and clinical potentials of normoxic HIF-2α expression in NB still remain largely unknown. In this study, HIF-2α immunostaining was identified in 26/42 NB tissues, which was correlated with clinicopathological features. In subtotal 20 NB cases, microRNA-145 (miR-145) was downregulated and inversely correlated with HIF-2α expression. Bioinformatics analysis revealed a putative miR-145 binding site in the 3'-untranslated region (3'-UTR) of HIF-2α messenger RNA (mRNA). Overexpression or knockdown of miR-145 responsively altered both the mRNA and protein levels of HIF-2α and its downstream genes, cyclin D1, matrix metalloproteinase 14 and vascular endothelial growth factor, in normoxically cultured NB cell lines SH-SY5Y and SK-N-SH. In a luciferase reporter system, miR-145 downregulated the luciferase activity of HIF-2α 3'-UTR, and these effects were abolished by a mutation in the putative miR-145-binding site. Overexpression of miR-145 suppressed the growth, invasion, metastasis and angiogenesis of SH-SY5Y and SK-N-SH cells in vitro and in vivo, while restoration of HIF-2α expression rescued the tumor cells from miR-145-mediated defects in these biological features. Furthermore, anti-miR-145 inhibitor rescued the HIF-2α knockdown-mediated repression on the growth, migration, invasion and angiogenesis of NB cells. These data indicate that miR-145 suppresses HIF-2α expression via the binding site in the 3'-UTR under normoxic conditions, thus inhibiting the aggressiveness and angiogenesis of NB.
Collapse
|
247
|
Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues G, Ward A, Boldt R, Palma D. Radiographic Changes After Lung Stereotactic Ablative Radiation Therapy (SABR) - Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
248
|
Wu RH, Lin R, Li H, Xiao ZW, Rao HB, Luo WH, Guo G, Huang K, Zhang XG, Lang ZJ. Accuracy of noninvasive quantification of brain NAA concentrations using PRESS sequence: verification in a swine model with external standard. CONFERENCE PROCEEDINGS : ... ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL CONFERENCE 2012; 2005:1396-9. [PMID: 17282459 DOI: 10.1109/iembs.2005.1616690] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
The metabolite ratios had been employed in the field of MR spectroscopy (MRS) for a long period. The main drawback of metabolite ratio is that ratio results are not comparable with absolute metabolite concentration in vivo. The purpose of this study was to examine the accuracy of noninvasive quantification of brain N-acetylaspartate (NAA) concentrations using previously reported MR external standard method. Eight swine were scanned on a GE 1.5 T scanner with a standard head coil. The external standard method was utilized with a sphere filled with NAA, GABA, glutamine, glutamate, creatine, choline chloride, and myo-inositol. The position resolved spectroscopy (PRESS) sequence was used with TE=135 msec, TR=1500 msec, and 128 scan averages. The analysis of MRS was done with SAGE/IDL program. In vivo NAA concentration was obtained using the equation S=N * e(-TE/T<sub>2</sub>) * [1-e(-TR/T<sub>1</sub>). In vitro NAA concentration was measured by high performance liquid chromatography (HPLC). In the MRS group, the mean concentration of NAA was 10.03 plusmn 0.74 mmol/kg. In the HPLC group, the mean concentration of NAA was 9.22 plusmn 0.55 mmol/kg. There was no significant difference between the two groups (p = 0.46). However, slightly higher value was observed in the MRS group (7/8 swine), compared with HPLC group. The range of differences was between 0.02~2.05 mmol/kg. MRS external reference method could be more accurate than internal reference method. <sup>1</sup>H MRS does not distinguish between N-acetyl resonance frequencies and other N-acetylated amino acids.
Collapse
|
249
|
Huang K, Li SQ, Wang WJ, Liu LS, Jiang YG, Feng PN, Wang YQ, Wang SM. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice. Int J Immunopathol Pharmacol 2012; 25:397-406. [PMID: 22697071 DOI: 10.1177/039463201202500209] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Orally administered immunomodulatory drugs have recently demonstrated the ability to induce an oral tolerance via inhibition of effector T cells and induction of certain subsets of regulatory T cells (Tregs) which have the potential to prevent several autoimmune diseases. In the present study, we hypothesized that short-term, low-dose, oral FTY720 administration may induce latency-associated peptide (LAP) Tregs and CD4(+) Foxp3(+) Tregs in atherogenesis, potentially resulting in remission of early development of atherosclerosis in apolipoprotein E-deficient (APOE(-/-)) mice. FTY720 was orally administered to APOE(-/-) mice 4 weeks of age on a high-cholesterol diet and atherosclerosis was assessed at 8 weeks of age. Oral administration of FTY720 significantly reduced atherosclerotic lesion formation compared with control mice. We observed a significant increase in LAP(+) and Foxp3(+) cells in the CD4+T-cell population of FTY720-treated mice in association with increased production of the anti-inflammatory cytokine transforming growth factor-β (TGF-β) as well as suppressed T-helper type 1 immune responses. Our findings reveal that short-term, low-dose oral FTY720 treatment had great benefits in inhibiting early development of atherosclerosis in mice via induction of a regulatory T-cell response and inhibition of effector T responses. These findings suggest that oral immune modulation may represent an attractive therapeutic approach to atherosclerosis.
Collapse
|
250
|
Huang C, Huang R, Chang W, Jiang T, Huang K, Cao J, Sun X, Qiu Z. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. Neoplasma 2012; 59:52-61. [PMID: 22082308 DOI: 10.4149/neo_2012_007] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Signal transducers and activators of transcription 3 (STAT3) is a central cytoplasmic transcription factor and regulates a number of pathways important in tumorigenesis including cell cycle progression, apoptosis, tumor angiogenesis, invasion and metastasis.This study aims to investigate the expression of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma and their relations to the clinicopathological features, tumor angiogenesis and prognosis. In the present study, the expression of pSTAT3, VEGF and VEGF-C and microvascular density (MVD) were examined via immunohistochemistry. The clinicopathological information was collected and patients were regularly followed up. The relationship between the parameters and the clinicopathological features were analyzed, and the univariate and multivariate prognostic factors were also analyzed. The expression of pSTAT3 in tumor tissues was significantly higher in contrast to that in normal tissues, and pSTAT3 was related to VEGF and VEGF-C expression, MVD, tumor size, lymphogenous status and TNM staging (P<0.05). Survival analysis suggested that tumor size, TNM staging, pSTAT3 and VEGF expression were risk factors of prognosis, but no independent factors were found. We concluded that pSTAT3, which was a risk factor of prognosis, was abnormally expressed in pancreatic adenocarcinoma and related to tumor size, TNM staging and lymphatic metastasis. pSTAT3 may promote tumor angiogenesis via up-regulating VEGF on protein and even gene levels, and enhance the early lymphatic metastasis through VEGF-C. Better understanding of STAT3 signaling pathways in angiogenesis may contribute to the development of novel therapeutic strategies in angiogenesis and metastasis of pancreatic cancer.
Collapse
|